EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Discovery and Characterization of Unusual O‐Linked Glycosylation of IgG4 Antibody Using LC‐MS

Dariusz J Janecki iD, Chi-Ya Kao-Scharf, Andreas Hoffmann

Rapid Communications in Mass Spectrometry · 2025

DOI: 10.1002/rcm.9969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2025. Verfasst von Dariusz J Janecki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sandoz Deutschland, Holzkirchen, Germany. Hauptthemen laut MEDLINE: Immunoglobulin G, Mass Spectrometry. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Consensus is that immunoglobulin IgG4 contains only N‐linked glycosylation. The analysis of several batches of commercial biopharmaceutical product Dupixent using top‐down intact mass spectrometry revealed that this IgG4 features a small amount of O‐linked glycosylation in the Fab region. This is the first report of an O‐linked glycosylation in an IgG4 antibody.

Methods

Monoclonal antibody solutions were subjected to cation exchange (CEX) and reverse phase (RP) chromatography and/or additional preconcentration/fractionation methods to prepare samples for subsequent analysis. Advanced MS analysis and fragmentation techniques (HCD, ETD, and EThcD) were employed to localize the O‐linked glycosylation as well as elucidate the structure of the glycan(s).

Results

O‐linked glycosylation in the IgG4 dupilumab was discovered by intact‐MS. The probable location was narrowed down to four sites in the CH1 domain, and the structure of the O‐linked glycan was determined to be of Core 1 type. The relative quantities of the modifications were low, but the glycosylation was consistently detected in several batches of Dupixent.

Conclusions

We discovered a rare glycosylation modification on dupilumab, an IgG4 antibody. The O‐linked glycosylation was characterized and localized in the Fab region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GMass SpectrometryGlycosylationChromatography, LiquidPolysaccharidesAntibodies, MonoclonalHumansAntibodies, Monoclonal, HumanizedLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

DupixentIgG4O‐linked glycosylationPTMglycosylation

Substanzen

Immunoglobulin GPolysaccharidesAntibodies, MonoclonalAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Sandoz Deutschland, Holzkirchen, Germany.

ORCID-Profile: Dariusz J Janecki

Zitieren

APA

Janecki, D. J., Kao-Scharf, C. Y., & Hoffmann, A. (2025). Discovery and Characterization of Unusual O‐Linked Glycosylation of IgG4 Antibody Using LC‐MS. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9969

Vancouver

Janecki DJ, Kao-Scharf CY, Hoffmann A. Discovery and Characterization of Unusual O‐Linked Glycosylation of IgG4 Antibody Using LC‐MS. Rapid Communications in Mass Spectrometry. 2025. doi:10.1002/rcm.9969

BibTeX
@article{Janecki2025,
  author = {Janecki, Dariusz J and Kao-Scharf, Chi-Ya and Hoffmann, Andreas},
  title = {Discovery and Characterization of Unusual O‐Linked Glycosylation of IgG4 Antibody Using LC‐MS},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2025},
  doi = {10.1002/rcm.9969}
}
Kostenlos starten →